Hib Disease and Vaccine Info
I hope this info is helpful.
Reported Cases Per Year Ages <5
2001 – 27
2002 – 34
2003 – 32
2004 – 19
2005 – 9
2006 – 29
2007 – 17
[CDC. Surveillance Summaries, 2001-2007. MMWR.]
“Ninety percent of individuals carry Hib bacteria in their nose and throat without showing signs of the disease. The organism enters the body through the nasopharynx. Organisms colonize the nasopharynx and may remain only transiently or for several months in the absence of symptoms (asymptomatic carrier). Nontypeable (unencapsulated) strains are also frequent inhabitants of the human respiratory tract.”
[The Pink Book, Chapter 9]
"There is little risk of getting the disease after age 5."
(Also from The Pink Book)
Major Clinical Manifestations
*Meningitis (50-65% of total cases, mortality rate 2-5%, neurological sequeale in 15-30% of survivors)
*Epiglottis (17% of cases)
*Arthritis (8%)
*Skin infection (6%)
*Pneumonia (15%)
*Bone infection (2%)
Breastfeeding Decreases Risk
Quote:
| “The association of decreased risk for invasive Hi infection and long duration of breastfeeding was persisting beyond the period of breastfeeding itself. This finding supports the hypothesis of a long-lasting protective effect of breastfeeding on the risk for invasive Hi infection.” |
[“Protective Effect of Breastfeeding on Invasive Haemophilus influenzae Infection: A Case-Control Study in Swedish Preschool Children.” International Journal of Epidemiology.]
Quote:
| “Breastmilk has a high concentration of secretory immunoglobulin and potentially could serve as a source of passive antibody protection of infants against systemic invasion by Haemophilus influenzae type b.” |
[“Breastmilk Antibody to the Capsular Polysaccharide of Hib.” Journal of Infectious Diseases.]
Short-term Side Effects, Clinical Trials on Package Insert
ACTHIB
-All trials include children vaccinated conmittantly with DTP, which is no longer used
PEDVAXHIB
-All trials include children vaccinated conmittantly with DTP and OPV, which are no longer used today
HIBTITER (only vaccine with trials in which children were given just the Hib and side effects were monitored)
-401 infants 1-6 months old given three doses alone, DTP two weeks later
-Adverse events recorded for two days
*33% irritability
*22% sleepiness
*9.5% prolonged crying >4 hours (!)
*6% appetite loss
*2.2% vomitting
*0.4% diarrhea
*0.2% rash
-354 children 15-23 months given one dose
-Adverse events recorded for one day
*2.5% diarrhea
*1.4% vomitting
*1.1% prolonged crying >4 hours
*0.5% rash
Side Effects in Medical Literature
*Antibody levels decrease immediately following vaccination (Daum, 1989; Marchant, 1989)
*2-6 times increased risk of Hib disease in seven days following vaccination (Black, 1988; Harrison, 1988; Osterholm, 1988; Shapiro, 1988; Hiner, 1988)
*Increased risk of seizures?
Vadheim et al:
-Group #1: vaccinated with DTP, OPV and Hib, had 5 seizures within 48 hours and 3 more within 3-14 days
-Group #2: vaccinated with DTP, OPV and Hep B, had 0 seizures within 48 hours and 2 within 3-14 days.
*GBS?
*Transverse myelitis?
*Thrombocytopenia?
*Causal relationship to diabetes (Classen, 1999; Karvoven, 1999)
Vaccine Effectiveness
Quote:
| “Vaccine effectiveness was estimated to be 56.7%.” |
[“Estimating Haemophilus Influenzae Type B Vaccine Effectiveness in England and Wales by Use of the Screening Method.” Journal of Infectious Diseases.]
Quote:
| “By using conditional logistic regression the vaccine effectiveness [against pneumonia] was estimated as 31.0%.” |
[“Effectiveness of Haemophilus Influenzae B Conjugate Vaccine on Childhood Pneumonia: A Case-control Study in Brazil.” International Journal of Epidemiology.]
“In 1998–2000… thirty-two percent of children aged 6-59 months with confirmed type b disease had received 3 or more doses of the vaccine…”
[CDC. “Progress Toward Elimination of Haemophilus influenzae Type B Disease Among Infants and Children – United States, 1998–2000.” MMWR.]
Serotype Replacement
Quote:
| “We show… an increase in virulence of non-b serotypes; and a concomitant increase in NC strains… Reduction of Hib carriage may open ecological niches for H. influenzae nontype-b strains and therefore potentially increase the risk of colonization and invasive disease by these strains.” |
[“Emergence of Nonencapsulated and Encapsulated Non-B-Type Invasive Haemophilus Influenzae Isolates in Portugal 1989-2001.” Journal of Clinical Microbiology.]
Quote:
| “In addition to the proportional increase in cases of nontype b H. influenzae disease in the post H. influenzae type b vaccine era, the incidence of invasive H. influenzae disease was found to be approaching the rates of H. influenzae type b disease that were documented in the prevaccine period. Fifty-six percent of invasive disease now occurs in individuals aged >10 years.” |
[“Characterization of Invasive Haemophilus Influenzae Disease in Manitoba, Canada, 2000-2006: Invasive Disease Due to Non-type B Strains.” Clinical Infectious Diseases.]
Quote:
| “The incidence of Hib meningitis decreased 69% during the 1-year period after initiation of Hib immunization (from 2.62 to 0.81 cases/100,000 person-years; P<.001). In contrast, the incidence for H. influenzae type a meningitis increased 8-fold. Therefore, Hib immunization contributed to an increased risk for H. influenzae type a meningitis through selection of circulating H. influenzae type a clones.” |
[“Prevention of Haemophilus Influenzae Type b (Hib) Meningitis and Emergence of Serotype Replacement with Type A Strains After Introduction of Hib Immunization in Brazil.” Journal of Infectious Diseases.]
Follow Mothering